Nicole Braccio, PharmD Candidate

home / authors / nicole-braccio-pharmd-candidate

Articles

Alcon Laboratories, Inc's Ilevro

Jeff Prescott, PharmD, RPh;Nicole Braccio, PharmD Candidate

May 17th 2013

Ilevro (nepafenac ophthalmic suspension) is approved to reduce pain and inflammation resulting from cataract surgery.

All JAKed Up and No Place to Go: A Critical Evaluation of the Role of JAK2 Inhibitors

Nicole Braccio, PharmD Candidate

April 23rd 2013

JAK therapies and their origins were discussed in an educational session at the 17th Annual International Congress on Hematologic Malignancies on February 15-17, 2013, in NYC.

Bristol-Myers Squibb's and Pfizer's Eliquis

Jeff Prescott, PharmD, RPh;Nicole Braccio, PharmD Candidate

April 18th 2013

Eliquis (apixaban) tablets are approved to reduce the risk of stroke and systemic embolism in adults with nonvalvular atrial fibrillation.

What Are the Best Ways to Use New Proteasome Inhibitors and IMiDs in Myeloma?

Nicole Braccio, PharmD Candidate

April 16th 2013

First-line treatment options and new therapies for the treatment of multiple myeloma were recently examined at the 17th International Congress on Hematologic Malignancies in NYC.